KTTA Pasithea Therapeutics Corp

NASDAQ
$0.54

Pasithea Therapeutics Corp (KTTA) SEC Filings

Everything KTTA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

1 filings
Date Form Filing
8-K DELISTING

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.